SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001239241-05-000009
Filing Date
2005-09-27
Accepted
2005-09-27 16:51:27
Documents
1
Period of Report
2005-09-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 12378
  Complete submission text file 0001239241-05-000009.txt   14225
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VENROCK ASSOCIATES 30 ROCKEFELLER PLAZA RM 5508 NEW YORK NY 21264957
Business Address
EVNIN ANTHONY B (Reporting) CIK: 0001239241 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51531 | Film No.: 051105842